UFE vs Myomectomy: Which Fibroid Treatment Is Right for You?
Both UFE and myomectomy preserve the uterus, making them important options for women who wish to avoid hysterectomy. However, they differ in approach, recovery, recurrence rates, and fertility implications.
Head-to-Head Comparison
| UFE | Myomectomy | |
|---|---|---|
| Type of Procedure | Minimally invasive (image-guided) | Surgery (open, laparoscopic, or hysteroscopic) |
| Anaesthesia | Conscious sedation | Usually general anaesthesia |
| Incision | Tiny puncture (wrist or groin) | Abdominal incision or keyhole |
| Hospital Stay | Overnight (1 night) | 1-3 days |
| Recovery Time | 1-2 weeks | 4-6 weeks |
| Uterus Preserved | Yes | Yes |
| Fibroids Treated | All fibroids (simultaneously) | Selected fibroids only |
| Symptom Improvement | 85-90% | 80-90% |
| Recurrence Risk | Low (5-10%) | Moderate (15-30%) |
| Fertility After Treatment | Possible (under investigation) | Established evidence |
| Scarring | Tiny puncture | Abdominal scar (open) or small incisions |
When UFE May Be Preferred
UFE may be the better choice when you have multiple fibroids that would be difficult to remove individually by surgery. Because UFE treats all fibroids simultaneously by blocking their blood supply, it is often more effective at addressing the complete fibroid burden than myomectomy, which may only remove selected fibroids.
Women who wish to avoid general anaesthesia and a surgical incision may prefer UFE, which is performed under sedation through a tiny puncture. The significantly shorter recovery time of 1-2 weeks (compared to 4-6 weeks for myomectomy) is also an important advantage for many patients.
UFE has a lower recurrence rate (5-10%) compared to myomectomy (15-30%), which may be relevant for women who want a more durable treatment outcome. Additionally, UFE avoids the formation of pelvic adhesions (scar tissue), which can occur after surgical myomectomy and may themselves cause pain or fertility problems.
When Myomectomy May Be Preferred
Myomectomy is generally the preferred option for women who are actively planning a pregnancy in the near future. There is a larger body of evidence supporting pregnancy outcomes after myomectomy, and it remains the standard recommendation for women whose primary concern is fertility.
For certain fibroid locations, myomectomy may offer specific advantages. Submucosal fibroids (those that protrude into the uterine cavity) can often be removed hysteroscopically, a procedure that requires no abdominal incision and has a very short recovery time. Pedunculated fibroids (those attached to the uterus by a stalk) may also be more easily addressed by surgery.
If you have a single, large fibroid in an accessible location, myomectomy can provide direct removal with good outcomes. Your gynaecological surgeon will assess whether the fibroid characteristics make surgical removal straightforward and likely to succeed.
Fertility Considerations
Fertility is often one of the most important factors in choosing between UFE and myomectomy. Both procedures preserve the uterus, but they differ in their evidence base for subsequent pregnancy.
Myomectomy has been used for decades to improve fertility in women with fibroids, and there is well-established evidence supporting its role in enhancing pregnancy rates. After myomectomy, most women are advised to wait 3-6 months before attempting conception to allow the uterus to heal.
UFE is an effective treatment for fibroid symptoms, and there are published reports of successful pregnancies following the procedure. However, the evidence on fertility outcomes after UFE is still evolving, and current guidelines from organisations such as NICE and the RCOG note that more research is needed in this area.
If fertility is your primary concern, we would recommend discussing both options thoroughly with our specialist team. In some cases, a combined approach or careful consideration of fibroid characteristics may influence the best course of action.
Recovery Comparison
Recovery from UFE is considerably shorter than from open or laparoscopic myomectomy. After UFE, most patients are discharged the next morning and return to normal activities within 1-2 weeks. Myomectomy recovery varies depending on the surgical approach: open myomectomy requires 4-6 weeks of recovery, while laparoscopic or hysteroscopic approaches may have shorter recovery periods of 2-4 weeks.
After myomectomy, patients are typically advised to avoid heavy lifting and strenuous exercise for 4-6 weeks. There may also be restrictions on driving for 2-4 weeks. After UFE, most patients can drive within a few days and resume gentle exercise within 1-2 weeks.
Both procedures may cause temporary changes to menstrual patterns. After UFE, periods usually begin to improve within the first two to three cycles. After myomectomy, symptoms generally improve once recovery is complete.
Making the Right Decision
The decision between UFE and myomectomy depends on several factors, including your fertility plans, the number and location of your fibroids, your preference for a minimally invasive approach, and how quickly you need to return to your normal routine.
At the North London Fibroid Clinic, our team of interventional radiologists and gynaecologists work together to provide a comprehensive assessment and help you understand which option is most likely to achieve your goals. We take the time to listen to your priorities and provide honest, evidence-based advice.
A consultation is the best way to determine which treatment is right for you. We will review your imaging, discuss your symptoms and concerns, and create a personalised treatment plan. To book an appointment, please contact us.
Frequently Asked Questions
References
- NICE Guideline [IPG367] — Uterine artery embolisation for fibroids. National Institute for Health and Care Excellence.
- Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database of Systematic Reviews.
- Manyonda I, et al. Uterine-artery embolization or myomectomy for uterine fibroids. New England Journal of Medicine, 2020.
- Royal College of Obstetricians and Gynaecologists. Clinical recommendations on the use of uterine artery embolisation (UAE) in the management of fibroids. RCOG, 3rd edition.
Discuss Your Treatment Options
Book a consultation with our specialist team for a personalised assessment
Or call us: 01305 608250